Benefits
Type 2 Diabetes Glycemic Control (24-Week RCT)
DeltaGold 250 mg/day for 24 weeks in 110 T2DM patients showed significant improvements in fasting blood glucose, HbA1c, insulin, HOMA-IR, plus reduced inflammation and oxidative stress markers (Phytotherapy Research 2021).
Cardiovascular Health
Multiple DeltaGold trials demonstrate cholesterol management (7-8% LDL reduction in T2DM trial), reduced inflammation, oxidative stress reduction.
Metabolic Syndrome
Delta- and gamma-tocotrienols more effective than alpha-tocotrienol/tocopherol at attenuating metabolic syndrome — established in multiple studies.
Bone Health (Postmenopausal Women)
Annatto tocotrienol shows promise as bone health promoter in postmenopausal women — published clinical evidence.
TOCOPHEROL-FREE Distinction
Critical — alpha-tocopherol interferes with tocotrienol uptake and function; DeltaGold is tocopherol-free unlike palm/rice tocotrienols (which contain interfering alpha-tocopherol).
FDA GRAS Status
First tocopherol-free tocotrienol product to receive FDA GRAS — enables food and beverage applications.
Patent-Protected US Manufacturing
Patented manufacturing process; US-based production.
Triglyceride Reduction
T2DM trial showed 10.3% triglyceride reduction with DeltaGold vs 0.9% placebo.
Mechanism of action
Delta- and Gamma-Tocotrienol Activity
Smaller chromanol head structure than alpha-T3 enables greater cell membrane penetration and stronger potency; superior to alpha forms in most metabolic applications.
HMG-CoA Reductase Modulation
Tocotrienols inhibit HMG-CoA reductase (cholesterol synthesis enzyme) — different mechanism than statins; cholesterol-lowering effects.
miRNA Modulation (T2DM Trial)
T2DM trial demonstrated 2-3-fold modifications in microRNAs associated with diabetes, inflammation, oxidative stress — sophisticated regulatory mechanism.
NF-kB Anti-Inflammatory
Delta- and gamma-T3 modulate NF-kB inflammatory pathway; reduce IL-6, TNF-alpha (15.9% and 13.7% reductions in T2DM trial).
Antioxidant Activity
Tocotrienols have superior free radical scavenging vs tocopherols due to unsaturated side chain enabling more efficient tissue incorporation.
No Interference from Alpha-Tocopherol
DeltaGold's tocopherol-free composition prevents alpha-tocopherol's interference with tocotrienol uptake and function.
Clinical trials
24-week randomized double-blind placebo-controlled trial of 250 mg/day DeltaGold in 110 T2DM patients.
110 patients with type 2 diabetes mellitus.
Significant improvements in fasting blood glucose, HbA1c, insulin, HOMA-IR. Triglycerides reduced 10.3% (vs 0.9% placebo). LDL cholesterol reduced 8.5%. IL-6 reduced 15.9%, TNF-alpha 13.7%. miRNA modulation. Confirmed first-in-class tocotrienol diabetes management.
Clinical study of annatto tocotrienol on bone markers in postmenopausal women.
Postmenopausal women.
Promising bone health promoter; supports healthy aging applications.
Multiple DeltaGold trials on cardiovascular and inflammatory markers.
Various populations including cardiovascular and metabolic concerns.
Lipid parameter improvements; reduced inflammatory biomarkers.